A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma.

ABSTRACT:

SUBMITTER: Qualls D 

PROVIDER: S-EPMC9631700 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature